Business Wire

THALES

18.2.2021 16:56:12 CET | Business Wire | Press release

Share
French Armed Forces to Rely on Thales Expertise to Expand Their Secure Satellite Communication Capabilities

Thales has been chosen by the French defence procurement agency (DGA) to lead a second part of the ground segment of the Syracuse IV satellite communications system for the French armed forces. The Group was selected to supply the satellites in 2015 and to lead the first increment of the ground segment in 2019. This second capacity increment will enhance the interoperable communications capabilities of the French Army, Navy and Air Force in terms of data rate, availability, threat resistance and end-to-end connectivity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210218005759/en/

Military satellite communications are more critical than ever and more vulnerable to attack; they are at the heart of the battle for strategic independence across all areas of military invention. Maintaining connectivity is key to the armed forces' ability to share information of all types between command centres and units deployed on any type of mission, including coalition operations.

This crucial programme milestone will enhance the performance of the ground segment across all theatres of operation for the three branches of the French military. The Thales solution will decisive in meeting the capacity requirements of land, naval and air force programmes such as Scorpion, FREMM, FDI, Barracuda, aircraft carrier, or Rafale. It aims to increase tenfold the secure communication capabilities of fighting vehicles on the move, surface vessels, submarines, and now also aircrafts. The Thales technology guarantees roaming communications in both X- and Ka-band and fully exploits the multi-spot potential of High Throughput Satellite (HTS) technology.

All the ground terminals in the system will be able to make optimum use of the Syracuse IV constellation. Their full interconnection via new docking terminals will allow considerable increase in data rate by ensuring joint cooperation in theatres of operations and with command centres. They will also be compatible with third-party satellite resources, depending on the area of deployment, without compromising communications security.

To achieve this objective, Thales will leverage its high-level systems integration expertise, and in particular its highly secure Modem 21 transmission system, to guarantee the availability and confidentiality of all communications and provide protection from the full spectrum of threats with no impact on operational performance, which is key to retaining information superiority in high-intensity combat. Thales’s NATO-standard Modem 21 solution has been proven in combat for over ten years.

The role of Thales Alenia Space in this contract will include mission management for the Syracuse constellation and management of the anchoring capabilities of the operator, the French Defence Ministry's joint infrastructure networks and information systems agency (DIRISI). Thales Alenia Space is also lead contractor for the contract notified by the DGA at the end of 2015 for the supply of the space segment consisting of the Syracuse 4A and 4B satellites and their control and mission ground segment.

Building on its expertise as a technology orchestrator and integrator for satellite communication systems in France and internationally, Thales has deployed over 1,000 secure, protected satcom stations worldwide, working with local industrial partners.

“As prime contractor for the Syracuse III and Syracuse IV ground segments since 2004, Thales is proud to strengthen its partnership with the French Ministry for the Armed Forces to help maintain the informational superiority of the country’s armed forces in highly contested environments. The sovereign satcom solutions to be supplied under this contract are resilient to all types of threats, combat-proven, and fully interoperable with the systems deployed by NATO coalition forces.” Marc Darmon, Executive Vice President, Secure Communications and Information Systems, Thales.

Note to editors

Syracuse is a series of protected telecommunication satellites designed to ensure that the French armed forces can communicate at all times between mainland France and units deployed around the world. The Syracuse programme provides a fully independent solution to France’s wide-ranging requirements for long-range, secure communication capabilities that are protected against electronic warfare threats. Three generations of Syracuse satellites were deployed between 1984 and 2015. The Syracuse IV programme will replace the Syracuse 3A and Syracuse 3B satellites currently in orbit, while delivering an expanded and upgraded network of ground stations. A constellation of two satellites has been ordered under the first phase of the Syracuse IV programme. They will be built by Thales Alenia Space and Airbus Defence and Space. The first satellite will enter service in 2022.

About Thales

Thales (Euronext Paris: HO) is a global high technology leader investing in digital and “deep tech” innovations –connectivity, big data, artificial intelligence, cybersecurity and quantum technology – to build a future we can all trust, which is vital to the development of our societies. The company provides solutions, services and products that help its customers – businesses, organisations and states – in the defence, aeronautics, space, transportation and digital identity and security markets to fulfil their critical missions, by placing humans at the heart of the decision-making process.

With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a basis including Gemalto over 12 months).

PLEASE VISIT

Thales Group

Download photos

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye